Predictors of talc pleurodesis outcome in patients with malignant pleural effusions

Lung Cancer

Volumn 62, Issue 1, 2008, Pages 139-144

  Yildirim, Huseyin ^a   Metintas, Muzaffer ^a   Ak, Güntülü ^a   Metintas, Selma ^a   Erginel, Sinan ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

ADA; Malignant pleural effusions; pH; Pleurodesis; Talc

Indexed keywords

ADENOSINE DEAMINASE; CHOLESTEROL; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; THORAX DRAINAGE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; ROC CURVE; SEX FACTORS; TALC; TREATMENT OUTCOME;

EID: 52149083279     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.02.017     Document Type: Article

References (14)

1. Antony V.B., Loddenkemper R., Astoul P., Boutin C., Goldstraw P., Hott J., et al. Management of malignant pleural effusions. Eur Respir J 18 (2001) 402-419
2. Pleural Disease Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of malignant pleural effusions. Thorax 58 (2003) ii29
3. Rodriguez-Panadero F., and Antony V.B. Therapeutic local procedures: pleurodesis. In: Loddenkemper R., and Antony V.B. (Eds). Pleural diseases (2002), ERS Journals Ltd., Leeds 311-326
4. Sahn S.A. Pleural disease related to metastatic malignancies. Eur Respir J 10 (1997) 1907-1913
5. Rodriguez-Panadero F., and Antony V.B. Pleurodesis: state of art. Eur Respir J 10 (1997) 1648-1654
6. Giusti G., and Galanti B. Adenosine deaminase. In: Bergmeyer H.V. (Ed). Methods of enzyme analysis (1983), Academic Press, New York, NY
7. Dresler C.M., Olak J., Herndon II J.E., Richards W.G., Scalzetti E., Fleishman S.B., et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127 (2005) 909-915
8. Psathakis K., Calderon-Osuna E., Romero-Romero B., Martin-Juan J., Romero-Falcon A., and Rodriguez-Panadero F. The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J 27 (2006) 817-821
9. Burrows C.M., Mathews C., and Colt H.G. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and qualify of life measures of extent of disease. Chest 117 (2000) 73-78
10. Martinez-Moragon E., Aparicio J., Sanchis J., Menedez R., Cruz Rogado M., and Sanchis F. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 65 (1998) 108-113
11. Aelony Y., King R.R., and Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH. Chest 113 (1998) 1007-1012
12. Heffner J.E., Nietert P.J., and Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure-analysis of primary data. Chest 117 (2000) 87-95
13. Goodman A., and Davies C.V.H. Efficacy of short term versus long term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions; a randomised trial. Lung Cancer 54 (2006) 51-55
14. Mager H.J., Maesen B., Verzijlbergen F., and Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 36 (2002) 77-81